NCT00807456

Brief Summary

The study aims to evaluate maintenance of lingual/palatinal marginal bone with the (ASTRA TECH Implant System) OsseoSpeed™ Profile implant in sites where the alveolar crest anatomy is sloped in a lingual to buccal direction. The hypothesis is that the sloped marginal contour of the implant will help preserve the lingual/palatinal marginal bone.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2008

Longer than P75 for not_applicable

Geographic Reach
3 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 11, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 12, 2008

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

May 30, 2016

Completed
Last Updated

November 17, 2022

Status Verified

November 1, 2022

Enrollment Period

4.6 years

First QC Date

December 11, 2008

Results QC Date

March 16, 2016

Last Update Submit

November 3, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone Level Changes at the Lingual Aspect From Implant Placement (Baseline) to Re-entry 16 Weeks After Implant Placement

    Clinical measurements after implant installation and after 16 weeks to determine bone levels at the buccal and lingual aspects in relation to a fixed landmark on the implant, i.e. the interface between the micro-threaded part and the shoulder at the marginal portion of the implants.The assessments were made using a periodontal probe and distances were measured to the nearest 0.5 mm. Negative value denotes loss of bone.

    At baseline and 16 weeks

Secondary Outcomes (5)

  • Implant Survival Rate

    21 weeks, 12 months, 24 months and 36 months post implant placement.

  • Marginal Bone Level (MBL) Change From Implant Placement Presented on Implant Level

    Baseline and 16 weeks, 21 weeks, 12 months, and 36 months post implant placement

  • Condition of Peri-Implant Tissues Measured Through Bleeding on Probing (BoP)

    21 weeks, 12 months, 24 months, and 36 months post implant placement

  • Condition of Peri-implant Tissues Measured by Average Change in Probing Pocket Depth (PPD) From Permanent Restoration

    Baseline and 12 months, 24 months, and 36 months post implant placement

  • Condition of Peri-implant Tissues Measured by Average Change in Clinical Attachment Level (CAL) From Permanent Restoration

    Baseline and 12 months, 24 months, and 36 months post implant placement

Study Arms (1)

Subjects treated with ASTRA TECH Implant System, OsseoSpeed™ Profile implant

EXPERIMENTAL
Device: ASTRA TECH Implant System, OsseoSpeed™

Interventions

ASTRA TECH Implant System, OsseoSpeed™ Profile implants: Ø4.5, 5.0, 5.0S mm in lengths of 9, 11, 13, 15mm.

Subjects treated with ASTRA TECH Implant System, OsseoSpeed™ Profile implant

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of informed consent
  • Aged 18-75 years at enrolment
  • A lingual-buccal difference in bone height between 2.0-5.0 mm at the implant site
  • History of edentulism in the study area of at least 3 months
  • Presence of alveolar bone crest dimensions judged by the investigator to allow ≥1mm of bone circumferential to the implant after implant placement.
  • In need for a single implant replacing a missing tooth in any location with an adjacent natural tooth mesially, and an adjacent natural tooth or edentulous space distally to the planned implant position (i.e. no existing or planned implant adjacent to the planned study implant position)
  • Deemed by the investigator as likely to present an initially stable implant situation

You may not qualify if:

  • Uncontrolled pathological processes in the oral cavity
  • Known or suspected current malignancy
  • History of radiation therapy in the head and neck region
  • History of chemotherapy within 5 years prior to surgery
  • Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
  • Uncontrolled diabetes mellitus
  • Corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration
  • Smoking more than 10 cigarettes per day
  • Present alcohol and/or drug abuse
  • Current need for bone grafting in the planned implant area
  • Previous enrolment in the present study
  • Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months
  • Involvement in the planning and conduct of the study (applies to both Sponsor staff or staff at the study site)
  • Unlikely to be able to comply with study procedures, as judged by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Department of Periodontology, College of Dental Medicine, Nova Southeastern University

Fort Lauderdale, Florida, 33328-2018, United States

Location

Department of Periodontics, Robert Schattner Center, School of Dental Medicine, University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Medizinische Hochschule Hannover

Hanover, D-30625, Germany

Location

Praxis Dr Robert Nölken

Lindau, D-88131, Germany

Location

Studio Dentistico Donati

Perugia, IT-06121, Italy

Location

Related Publications (1)

  • Noelken R, Donati M, Fiorellini J, Gellrich NC, Parker W, Wada K, Berglundh T. Soft and hard tissue alterations around implants placed in an alveolar ridge with a sloped configuration. Clin Oral Implants Res. 2014 Jan;25(1):3-9. doi: 10.1111/clr.12079. Epub 2012 Dec 5.

Results Point of Contact

Title
Manager Global Clinical Affairs
Organization
DENTSPLY Implants

Study Officials

  • Tord Berglundh, Prof.

    Department of Periodontology, Sahlgrenska Academy at University of Gothenburg

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2008

First Posted

December 12, 2008

Study Start

November 1, 2008

Primary Completion

June 1, 2013

Study Completion

December 1, 2013

Last Updated

November 17, 2022

Results First Posted

May 30, 2016

Record last verified: 2022-11

Locations